Article Details

CTI BioPharma Announces Completion of Rolling Submission of New Drug Application (NDA) for ...

Retrieved on: 2021-03-31 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

CTI BioPharma Announces Completion of Rolling Submission of New Drug Application (NDA) for .... View article details on hiswai:

Excerpt

SEATTLE, March 31, 2021 /PRNewswire/ --CTI BioPharma Corp. (Nasdaq: CTIC) today announced that it has completed a rolling New Drug ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up